Skip to main content

Kristen Fortney

Equibles does not estimate personal net worth.

Get an email with a short summary when BioAge Labs, Inc. publishes a filing, an earnings call transcript or a press release.

Get BIOA alerts

About Kristen Fortney

Kristen Fortney is recorded as CEO at BioAge Labs, Inc. (BIOA). The newest filing on record that lists Kristen Fortney as CEO at BioAge Labs, Inc. (BIOA) is dated April 21, 2026. The proxy statement of BioAge Labs, Inc. reports total compensation of $2,886,590 for Kristen Fortney in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 3 fiscal years. Kristen Fortney has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for BioAge Labs, Inc. on November 10, 2026. BioAge Labs, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at BioAge Labs, Inc. includes Dov Goldstein (CFO) and Eric Morgen (COO).

Kristen Fortney on recent calls

“And thanks, Seamus, for having me here today. We're pleased to be here. Looking forward to the conference.”
CEO, Guggenheim 3rd Annual Healthcare Innovation Conference ·
“No, as you said, it's been a super eventful year for us and for the target. So, you know, when the year started in January, we were in the middle of our phase one.”
CEO, Citi Biopharma Back to School Conference ·
“So we are a clinical stage biotech company, and we are applying human aging biology as a lens for target discovery and development of therapies for cardiometabolic disease.”
CEO, Goldman Sachs Global Healthcare Conference ·
“We're very excited to share our phase one results for BGE 102 today. We believe these data, showing profound HSCRP reductions with a well-tolerated once-daily oral dose, positioned BGE-102 as a potential best-in-class NLRP3 inhibitor, and they've given us strong conviction to really accelerate the program.”
CEO, BioAge Labs, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at BioAge Labs, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 BioAge Labs, Inc. (BIOA) $600,000 $2,886,590
2024 BioAge Labs, Inc. (BIOA) $520,994 $12,226,906
2023 BioAge Labs, Inc. (BIOA) $493,271 $1,380,475

Recent activity